<unk>  is an anticonvulsant used to reduce the occurrence of epileptic episodes, and is not intended to cure epilepsy.<unk>  is used alone or in combination with other medications for the treatment of focal (partial) seizures in adults. In pediatric populations, it can be used by itself for the treatment of partial seizures for children 4 years and older, or in combination with other medications for children 2 years and older. There is some evidence to support its effectiveness in reducing seizure frequency when used as an add-on therapy for drug-resistant focal epilepsy but there are concerns over tolerability. Research has investigated the use of<unk>  as a mood stabilizer in bipolar disorder, with further evidence needed to fully assess its suitability. It may be beneficial in trigeminal neuralgia. Pregnancy<unk>  is listed as pregnancy category C. There is limited data analyzing the impact of<unk>  on a human fetus. Animal studies have shown increased fetal abnormalities in pregnant rats and rabbits exposed to<unk>  during pregnancy. In addition,<unk>  is structurally similar to carbamazepine, which is considered to be teratogenic in humans (pregnancy category D).<unk>  should only be used during pregnancy if the benefits justify the risks. Pregnant women on<unk>  should be closely monitored, as plasma levels of the active metabolite licarbazepine have been shown to potentially decrease during pregnancy. Breastfeeding<unk>  and its metabolite licarbazepine are both present in human breast milk and thus, some of the active drug can be transferred to a nursing infant. When considering whether to continue this medication in nursing mothers, the impact of the drug's side effect profile on the infant, should be weighed against its anti-epileptic benefit for the mother.
Oxcarbazepine
Carbamazepine
Capsazepine
Nitroxazepine
Propazepine
Eslicarbazepine acetate
Lamotrigine
Phenytoin